-
Chronic Lymphocytic Leukemia (CLL)
Especially in patients who have relapsed or have high-risk genetic features. -
Follicular Lymphoma (FL)
For patients whose cancer has returned after at least two previous treatments. -
Small Lymphocytic Lymphoma (SLL)
A slow-growing form of non-Hodgkin’s lymphoma.
Sale!
![]()
IDEENAT 150MG
IDELALISIB 150MG
| MRP | : |
|
| Price | : | ₹15,000.00 |
| You Save | : | ₹2,812.50 (15.79%) |
30 Tablet(s) In A Bottle
Ideenat 150mg Tablet is an oral anticancer medication utilized for treating specific blood cancers such as chronic lymphocytic leukemia (CLL), follicular lymphoma (FL), and small lymphocytic lymphoma (SLL). It is classified as a targeted therapy that inhibits the function of a specific enzyme within cancer cells, thereby aiding in the cessation of their growth and survival.
This medication is typically prescribed to adults who have previously undergone other cancer treatments that were either ineffective or have lost their efficacy. It is frequently administered alongside other medications as part of a comprehensive long-term management strategy for certain lymphomas. Ideenat 150 Tablet 30’s is available only by prescription and should be taken under the guidance of a cancer specialist.
